Cargando…
Development of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine
SIMPLE SUMMARY: Virus-like particles (VLPs) have attracted significant interest as immunotherapy platforms and cancer vaccines for inducing antigen-specific immune responses against tumors. We prepared a human epidermal growth factor receptor-2 (HER2) cancer vaccine, by conjugating the HER2-derived...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230452/ https://www.ncbi.nlm.nih.gov/pubmed/34200802 http://dx.doi.org/10.3390/cancers13122909 |